BRANFORD, Conn.–(BUSINESS WIRE)–Oct. 17, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results for the third quarter 2023 on Thursday, November 9, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same […]
Remarks from Senior Vice President of Product Development John Vieceli will highlight the Company’s scalable next-generation Protein Sequencing™ technology to analyze the proteome with single amino acid resolution BRANFORD, Conn.–(BUSINESS WIRE)–Oct. 3, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the Company and Senior Vice President of […]
BRANFORD, Conn.–(BUSINESS WIRE)–Sep. 21, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Amir Jafri, President and CEO of Immunicom, Inc., to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230921747791/en/ (Photo: Business Wire) “Amir’s leadership track record speaks […]
BRANFORD, Conn.–(BUSINESS WIRE)–Aug. 22, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Platinum™, the world’s first next-generation protein sequencing instrument, has been honored in Fast Company’s Innovation by Design Awards for 2023 in the Products category. The Innovation by Design Awards, which can be found in […]
BRANFORD, Conn.–(BUSINESS WIRE)–Aug. 16, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted a non-qualified stock option award to purchase an aggregate of 200,000 shares of its Class A common stock to one new employee under the […]
BRANFORD, Conn.–(BUSINESS WIRE)–Aug. 14, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted non-qualified stock option awards to purchase an aggregate of 739,750 shares of its Class A common stock to 8 new employees under the Company’s […]
BRANFORD, Conn.–(BUSINESS WIRE)–Aug. 7, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the second quarter ended June 30, 2023. Second Quarter Highlights Recognized revenue of $205,000 in the second quarter of 2023. Exited the quarter with an order backlog of two Platinum™ instruments. Strengthened […]
BRANFORD, Conn.–(BUSINESS WIRE)–Jul. 26, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the Canaccord Genuity 43rd Annual Growth Conference taking place at the InterContinental Boston Hotel on August 7-10, 2023. Jeff Hawkins, Quantum-Si’s Chief Executive Officer, will participate in the panel […]
BRANFORD, Conn.–(BUSINESS WIRE)–Jul. 18, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results for the second quarter 2023 on Monday, August 7, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same […]
BRANFORD, Conn.–(BUSINESS WIRE)–Jun. 21, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Johan Denecke as Senior Vice President of Operations, effective June 20, 2023. Mr. Denecke will be responsible for scaling up production and driving operational and quality excellence in support of the commercialization […]